Similarity between the in vitro activity and toxicity of two different fungizone™ / lipofundin™ admixtures

Detalhes bibliográficos
Autor(a) principal: Araújo,Ivonete Batista
Data de Publicação: 2005
Outros Autores: Brito,C. Ramon N., Urbano,Isabel A., Dominici,Victor A., Silva Filho,Miguel A., Silveira,Walteçá L. L., Damasceno,Bolívar P. G. L., Medeiros,Aldo Cunha, Egito,E. Sócrates T.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Acta Cirúrgica Brasileira (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502005000700022
Resumo: PURPOSE: Amphotericin B (AmB), an antifungal agent that presents a broad spectrum of activity, remains the gold standard in the antifungal therapy. However, sometimes the high level of toxicity forbids its clinical use. The aim of this work was to evaluate and compare the efficacy and toxicity in vitro of Fungizon™ (AmB-D) and two new different AmB formulations. METHODS: three products were studied: Fungizon™, and two Fungizon™ /Lipofundin™ admixtures, which were diluted through two methods: in the first one, Fungizon™ was previously diluted with water for injection and then, in Lipofundin™ (AmB-DAL); the second method consisted of a primary dilution of AmB-D as a powder in the referred emulsion (AmB-DL). For the in vitro assay, two cell models were used: Red Blood Cells (RBC) from human donors and Candida tropicallis (Ct). The in vitro evaluation (K+ leakage, hemoglobin leakage and cell survival rate-CSR) was performed at four AmB concentrations (from 50 to 0.05mg.L-1). RESULTS: The results showed that the action of AmB was not only concentration dependent, but also cellular type and vehicle kind dependent. At AmB concentrations of 50 mg.L-1, although the hemoglobin leakage for AmB-D was almost complete (99.51), for AmB-DAL and AmB-DL this value tended to zero. The p = 0.000 showed that AmB-D was significantly more hemolytic. CONCLUSION: The Fungizon™-Lipofundin™ admixtures seem to be the more valuable AmB carrier systems due to their best therapeutic index presented.
id SBDPC-1_77339edd9a30dbf8acf68b3ecd6eee2b
oai_identifier_str oai:scielo:S0102-86502005000700022
network_acronym_str SBDPC-1
network_name_str Acta Cirúrgica Brasileira (Online)
repository_id_str
spelling Similarity between the in vitro activity and toxicity of two different fungizone™ / lipofundin™ admixturesFungizon™Lipofundin™amphotericin BFungal infectionDrug deliveryRed Blood CellsPURPOSE: Amphotericin B (AmB), an antifungal agent that presents a broad spectrum of activity, remains the gold standard in the antifungal therapy. However, sometimes the high level of toxicity forbids its clinical use. The aim of this work was to evaluate and compare the efficacy and toxicity in vitro of Fungizon™ (AmB-D) and two new different AmB formulations. METHODS: three products were studied: Fungizon™, and two Fungizon™ /Lipofundin™ admixtures, which were diluted through two methods: in the first one, Fungizon™ was previously diluted with water for injection and then, in Lipofundin™ (AmB-DAL); the second method consisted of a primary dilution of AmB-D as a powder in the referred emulsion (AmB-DL). For the in vitro assay, two cell models were used: Red Blood Cells (RBC) from human donors and Candida tropicallis (Ct). The in vitro evaluation (K+ leakage, hemoglobin leakage and cell survival rate-CSR) was performed at four AmB concentrations (from 50 to 0.05mg.L-1). RESULTS: The results showed that the action of AmB was not only concentration dependent, but also cellular type and vehicle kind dependent. At AmB concentrations of 50 mg.L-1, although the hemoglobin leakage for AmB-D was almost complete (99.51), for AmB-DAL and AmB-DL this value tended to zero. The p = 0.000 showed that AmB-D was significantly more hemolytic. CONCLUSION: The Fungizon™-Lipofundin™ admixtures seem to be the more valuable AmB carrier systems due to their best therapeutic index presented.Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia2005-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502005000700022Acta Cirúrgica Brasileira v.20 suppl.1 2005reponame:Acta Cirúrgica Brasileira (Online)instname:Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)instacron:SBDPC10.1590/S0102-86502005000700022info:eu-repo/semantics/openAccessAraújo,Ivonete BatistaBrito,C. Ramon N.Urbano,Isabel A.Dominici,Victor A.Silva Filho,Miguel A.Silveira,Walteçá L. L.Damasceno,Bolívar P. G. L.Medeiros,Aldo CunhaEgito,E. Sócrates T.eng2007-05-28T00:00:00Zoai:scielo:S0102-86502005000700022Revistahttps://www.bvs-vet.org.br/vetindex/periodicos/acta-cirurgica-brasileira/https://old.scielo.br/oai/scielo-oai.php||sgolden@terra.com.br0102-86501678-2674opendoar:2007-05-28T00:00Acta Cirúrgica Brasileira (Online) - Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)false
dc.title.none.fl_str_mv Similarity between the in vitro activity and toxicity of two different fungizone™ / lipofundin™ admixtures
title Similarity between the in vitro activity and toxicity of two different fungizone™ / lipofundin™ admixtures
spellingShingle Similarity between the in vitro activity and toxicity of two different fungizone™ / lipofundin™ admixtures
Araújo,Ivonete Batista
Fungizon™
Lipofundin™
amphotericin B
Fungal infection
Drug delivery
Red Blood Cells
title_short Similarity between the in vitro activity and toxicity of two different fungizone™ / lipofundin™ admixtures
title_full Similarity between the in vitro activity and toxicity of two different fungizone™ / lipofundin™ admixtures
title_fullStr Similarity between the in vitro activity and toxicity of two different fungizone™ / lipofundin™ admixtures
title_full_unstemmed Similarity between the in vitro activity and toxicity of two different fungizone™ / lipofundin™ admixtures
title_sort Similarity between the in vitro activity and toxicity of two different fungizone™ / lipofundin™ admixtures
author Araújo,Ivonete Batista
author_facet Araújo,Ivonete Batista
Brito,C. Ramon N.
Urbano,Isabel A.
Dominici,Victor A.
Silva Filho,Miguel A.
Silveira,Walteçá L. L.
Damasceno,Bolívar P. G. L.
Medeiros,Aldo Cunha
Egito,E. Sócrates T.
author_role author
author2 Brito,C. Ramon N.
Urbano,Isabel A.
Dominici,Victor A.
Silva Filho,Miguel A.
Silveira,Walteçá L. L.
Damasceno,Bolívar P. G. L.
Medeiros,Aldo Cunha
Egito,E. Sócrates T.
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Araújo,Ivonete Batista
Brito,C. Ramon N.
Urbano,Isabel A.
Dominici,Victor A.
Silva Filho,Miguel A.
Silveira,Walteçá L. L.
Damasceno,Bolívar P. G. L.
Medeiros,Aldo Cunha
Egito,E. Sócrates T.
dc.subject.por.fl_str_mv Fungizon™
Lipofundin™
amphotericin B
Fungal infection
Drug delivery
Red Blood Cells
topic Fungizon™
Lipofundin™
amphotericin B
Fungal infection
Drug delivery
Red Blood Cells
description PURPOSE: Amphotericin B (AmB), an antifungal agent that presents a broad spectrum of activity, remains the gold standard in the antifungal therapy. However, sometimes the high level of toxicity forbids its clinical use. The aim of this work was to evaluate and compare the efficacy and toxicity in vitro of Fungizon™ (AmB-D) and two new different AmB formulations. METHODS: three products were studied: Fungizon™, and two Fungizon™ /Lipofundin™ admixtures, which were diluted through two methods: in the first one, Fungizon™ was previously diluted with water for injection and then, in Lipofundin™ (AmB-DAL); the second method consisted of a primary dilution of AmB-D as a powder in the referred emulsion (AmB-DL). For the in vitro assay, two cell models were used: Red Blood Cells (RBC) from human donors and Candida tropicallis (Ct). The in vitro evaluation (K+ leakage, hemoglobin leakage and cell survival rate-CSR) was performed at four AmB concentrations (from 50 to 0.05mg.L-1). RESULTS: The results showed that the action of AmB was not only concentration dependent, but also cellular type and vehicle kind dependent. At AmB concentrations of 50 mg.L-1, although the hemoglobin leakage for AmB-D was almost complete (99.51), for AmB-DAL and AmB-DL this value tended to zero. The p = 0.000 showed that AmB-D was significantly more hemolytic. CONCLUSION: The Fungizon™-Lipofundin™ admixtures seem to be the more valuable AmB carrier systems due to their best therapeutic index presented.
publishDate 2005
dc.date.none.fl_str_mv 2005-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502005000700022
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502005000700022
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0102-86502005000700022
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia
publisher.none.fl_str_mv Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia
dc.source.none.fl_str_mv Acta Cirúrgica Brasileira v.20 suppl.1 2005
reponame:Acta Cirúrgica Brasileira (Online)
instname:Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)
instacron:SBDPC
instname_str Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)
instacron_str SBDPC
institution SBDPC
reponame_str Acta Cirúrgica Brasileira (Online)
collection Acta Cirúrgica Brasileira (Online)
repository.name.fl_str_mv Acta Cirúrgica Brasileira (Online) - Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)
repository.mail.fl_str_mv ||sgolden@terra.com.br
_version_ 1752126437821775872